Should we look beyond the interferon signature in chilblain‐like lesions associated with COVID‐19?-Reference-Cited by-同舟云学术

Should we look beyond the interferon signature in chilblain‐like lesions associated with COVID‐19?

Published:2021-11-08 Issue:6 Volume:185 Page:1090-1091
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Pilkington S.M.¹²^ORCID,Watson R.E.B.¹²^ORCID

Affiliation:

1. Centre for Dermatology Research School of Biological Sciences The University of Manchester & Salford Royal NHS Foundation Trust ManchesterUK

2. NIHR Manchester Biomedical Research Centre Manchester University NHS Foundation Trust Manchester Academic Health Science Centre Manchester UK

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20784

Reference12 articles.

1. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic

2. Vascular skin manifestations in patients with severe COVID‐19 in intensive care units: a monocentric prospective study;Dezoteux F;Eur J Dermatol,2021

3. Genetic interferonopathies: An overview

4. Type I interferons in infectious disease

5. Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak*

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review;Journal of Cutaneous Medicine and Surgery;2023-02-21

2. Autoimmune Diseases and Vasculopathies of the Lower Extremity;Atlas of Lower Extremity Skin Disease;2022